Drug Profile
AVX 901
Alternative Names: AVX901; DUKE-002-VRP; HER2 ECDTM VRP; HER2 VRP; HUHER2-ECD+TM; VRP HER2 ECDTM; VRP-HER2Latest Information Update: 02 Jan 2023
Price :
$50
*
At a glance
- Originator AlphaVax
- Developer Duke University; Merck Sharp & Dohme
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Breast cancer